Hopebridge’s Impact on ABA Services at CASP 2026

Hopebridge showcases their leadership in ABA services through multiple sessions at CASP 2026, addressing key challenges in the industry.
Understanding Psilocybin: Trump’s Initiative for Mental Health Treatments

This article delves into psilocybin research and the U.S. government’s support for psychedelic treatment in mental health.
Justice Department Reclassifies Marijuana: Impacts on Healthcare

The Justice Department’s recent decision to reclassify marijuana products to Schedule III impacts healthcare and research opportunities.
EHRs in Behavioral Health: The Need for Better Data Sharing

While behavioral health has improved EHR adoption, data sharing remains a significant hurdle. This article explores the current landscape and potential solutions.
Trends in Behavioral Health: Q1 2026 M&A Insights

This article dissects the evolving landscape of healthcare mergers and acquisitions, highlighting significant transactions in the behavioral health sector in Q1 2026.
Connecticut Fines Insurers for Mental Health Parity Violations

The Connecticut Insurance Department has fined multiple insurers for alleged mental health parity violations related to inadequate networks and disparate rates.
Behavioral Health Clinicians Spend 40% of Their Time on Paperwork. That’s a Staffing Problem.

The documentation burden in behavioral health drives clinician burnout and early departure. This guide gives behavioral health administrators a framework for measuring and reducing documentation burden effectively.
EHR Adoption in Behavioral Health: A Hiring and Staffing Guide for Practice Leaders

This article reviews the recent trends in EHR adoption among substance use and mental health treatment facilities.
Novant Health and Amae Expand Behavioral Health Services in Charlotte

Novant Health and Amae Health join forces to launch a new clinic focused on severe mental illness in Charlotte, enhancing care coordination and reducing hospital readmissions.
Study Reveals 8 Million Americans Used Psilocybin Last Year

A study published in The American Journal of Psychiatry shows that 8 million Americans used psilocybin in the past year, with notable demographic insights.